|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA03110244
|
ent-5,12-diepi-12-D2t-IsoP
|
4-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110199
|
ent-5,12-diepi-12-E2c-IsoP
|
4-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110200
|
ent-5,12-diepi-12-E2t-IsoP
|
4-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110235
|
ent-5,8-diepi-5-D2c-IsoP
|
(S,E)-5-hydroxy-7-((1R,2R,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110236
|
ent-5,8-diepi-5-D2t-IsoP
|
(S,E)-5-hydroxy-7-((1S,2S,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110064
|
ent-5-D2c-IsoP
|
5R,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110077
|
ent-5-D2t-IsoP
|
5R,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110181
|
ent-5-E2c-IsoP
|
(R,E)-5-hydroxy-7-((1S,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110182
|
ent-5-E2t-IsoP
|
(R,E)-5-hydroxy-7-((1R,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110241
|
ent-5-epi-12-D2c-IsoP
|
4-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110242
|
ent-5-epi-12-D2t-IsoP
|
4-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110201
|
ent-5-epi-12-E2c-IsoP
|
4-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110202
|
ent-5-epi-12-E2t-IsoP
|
4-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110067
|
ent-5-epi-5-D2c-IsoP
|
5S,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110068
|
ent-5-epi-5-D2t-IsoP
|
5S,9R-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110179
|
ent-5-epi-5-E2c-IsoP
|
(S,E)-5-hydroxy-7-((1S,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110180
|
ent-5-epi-5-E2t-IsoP
|
(S,E)-5-hydroxy-7-((1R,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110227
|
ent-8,11-diepi-8-D2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2R,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110228
|
ent-8,11-diepi-8-D2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2S,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110208
|
ent-8,11-diepi-8-E2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110207
|
ent-8,11-diepi-8-E2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110129
|
ent-8,15-diepi-15-D2c-IsoP
|
11-oxo-9R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110130
|
ent-8,15-diepi-15-D2t-IsoP
|
11-oxo-9R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110122
|
ent-8,15-diepi-15-E2t-IsoP
|
9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110183
|
ent-8,5-diepi-5-E2c-IsoP
|
(S,E)-5-hydroxy-7-((1R,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110184
|
ent-8,5-diepi-5-E2t-IsoP
|
(S,E)-5-hydroxy-7-((1S,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110050
|
ent-8-D2c-IsoP
|
8R,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110055
|
ent-8-D2t-IsoP
|
8R,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110206
|
ent-8-E2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110205
|
ent-8-E2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110128
|
ent-8-epi-15-D2c-IsoP
|
11-oxo-9R,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110115
|
ent-8-epi-15-E2c-IsoP
|
9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110233
|
ent-8-epi-5-D2c-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110234
|
ent-8-epi-5-D2t-IsoP
|
(R,E)-5-hydroxy-7-((1S,2S,5R)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110185
|
ent-8-epi-5-E2c-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110186
|
ent-8-epi-5-E2t-IsoP
|
(R,E)-5-hydroxy-7-((1S,2S,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110053
|
ent-8-epi-8-D2c-IsoP
|
8S,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110054
|
ent-8-epi-8-D2t-IsoP
|
8S,12R-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110210
|
ent-8-epi-8-E2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110209
|
ent-8-epi-8-E2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110107
|
ent-PGD2
|
9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110106
|
ent-PGE2
|
9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03140001
|
10,11-dihydro-Resolvin E1
|
5S,12,18S-trihydroxy-6Z,8E,14Z,16E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Resolvin Es [FA0314]
|
352.22
|
C20H32O5
|
|
LMFA03150002
|
15R-hydroxy-12S,14R-dioxolane-5Z,8Z,10E-eicosatrienoic acid
|
15R-hydroxy-12S,14R-dioxolane-5Z,8Z,10E-eicosatrienoic acid
|
Eicosanoids [FA03]
|
Eicosa-1,2-dioxolanes [FA0315]
|
352.22
|
C20H32O5
|
|
LMFA04000106
|
Ectocarpin D
|
(5E,8E,11E)-12-{(1'R,2'S,3'S,5'S)-2',3'-dihydroxy-5'-[(1''R)-1''-hydroxypropyl]cyclopentyl}-5,8,11-dodecatrienoic acid
|
Docosanoids [FA04]
|
Other Docosanoids [FA0400]
|
352.22
|
C20H32O5
|